SCHEMBL3784995

SCHEMBL3784995

Nc1cc(-c2ccccc2N)ccc1Oc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.57
▸ CYP2C9 P11712 2/20 0.57
▸ CYP2C19 P33261 2/20 0.57
▸ CYP3A4 P08684 1/20 0.57
▸ ALDH1A1 P00352 4/20 0.48
▸ HSD17B10 Q99714 1/20 0.48
▸ BRD4 O60885 1/20 0.47
▸ NCOA1 Q15788 1/20 0.45
▸ NCOA3 Q9Y6Q9 1/20 0.45
▸ IKBKB O14920 1/20 0.44
▸ BRAF P15056 1/20 0.44
▸ GAA P10253 2/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ ADORA2A P29274 1/20 0.43
▸ HTT P42858 2/20 0.43
▸ MAPT P10636 2/20 0.42
▸ RCE1 Q9Y256 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3790795 0.86 ALDH1A1 (0.48) CYP1A2CYP2C9CYP2C19CYP3A4ALDH1A1
SCHEMBL30393807 0.85 CYP1A2 (0.65) CYP1A2CYP2C9CYP2C19CYP3A4ALDH1A1
SCHEMBL3789145 0.84 CYP1A2 (0.62) CYP1A2CYP2C9CYP2C19CYP3A4ALDH1A1
SCHEMBL31090802 0.84 CYP1A2 (0.62) CYP1A2CYP2C9CYP2C19CYP3A4ALDH1A1
SCHEMBL30393884 0.82 CYP1A2 (0.61) CYP1A2CYP2C9CYP2C19CYP3A4ALDH1A1
SCHEMBL3784764 0.81 CYP3A4 (0.59) CYP1A2CYP2C9CYP2C19CYP3A4ALDH1A1
SCHEMBL11135655 0.80 IKBKB (0.60) CYP1A2CYP2C9CYP2C19CYP3A4ALDH1A1
SCHEMBL398444 0.80 ALDH1A1 (0.64) ALDH1A1HSD17B10NCOA1NCOA3MEN1
SCHEMBL2087211 0.79 ALDH1A1 (0.57) ALDH1A1HSD17B10NCOA1NCOA3GAA
SCHEMBL3787032 0.79 ALDH1A1 (0.55) CYP3A4ALDH1A1HSD17B10NCOA1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 — — US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 CYP1A2 170/4885CYP2C9 157/4885CYP2C19 196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback